Novo Integrated Sciences Inc. (NASDAQ: NVOS) is -35.71% lower on its value in year-to-date trading and has touched a low of $0.97 and a high of $14.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVOS stock was last observed hovering at around $2.66 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $2.70, the stock is 0.02% and -23.99% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.56 million and changing 1.50% at the moment leaves the stock -28.99% off its SMA200. NVOS registered -19.40% loss for a year compared to 6-month loss of -29.87%. The firm has a 50-day simple moving average (SMA 50) of $4.1532 and a 200-day simple moving average (SMA200) of $4.1532.
The stock witnessed a -22.86% gain in the last 1 month and extending the period to 3 months gives it a -58.46%, and is 13.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.97% over the week and 9.33% over the month.
Novo Integrated Sciences Inc. (NVOS) has around 73 employees, a market worth around $71.23M and $7.10M in sales. Profit margin for the company is -90.40%. Distance from 52-week low is 178.35% and -81.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.80%).
Novo Integrated Sciences Inc. (NVOS) Analyst Forecasts
Novo Integrated Sciences Inc. (NVOS) Top Institutional Holders
The shares outstanding are 23.75M, and float is at 5.67M with Short Float at 0.29%.
Novo Integrated Sciences Inc. (NVOS) Insider Activity
A total of 3 insider transactions have happened at Novo Integrated Sciences Inc. (NVOS) in the last six months, with sales accounting for 0 and purchases happening 3 times. The most recent transaction is an insider purchase by Oliva Robert Letterio, the company’s Director. SEC filings show that Oliva Robert Letterio bought 13,000 shares of the company’s common stock on Apr 21 at a price of $2.12 per share for a total of $27560.0. Following the purchase, the insider now owns 0.21 million shares.